Recombinant Rhabdovirus containing a heterologous fusion protein
    3.
    发明授权
    Recombinant Rhabdovirus containing a heterologous fusion protein 失效
    含有异源融合蛋白的重组狂犬病病毒

    公开(公告)号:US06497873B1

    公开(公告)日:2002-12-24

    申请号:US09217967

    申请日:1998-12-22

    IPC分类号: A01N6300

    摘要: This invention relates to a composition comprising a recombinant or genetically engineered Rhabdovirus that expresses a Fusion Protein, such as the F protein of the Paramyxovirus SV5 strain. This recombinant Rhabdovirus may express other non-Rhabdovirus attachment proteins and/or an enhancer protein. The invention also relates to methods of making recombinant Rhabdoviruses which express an F Protein. These recombinant compositions can be used for purposes of research, as well as for diagnostic and therapeutic compositions for treatment of diseases.

    摘要翻译: 本发明涉及包含表达融合蛋白的重组或遗传工程化的Rhabdovirus的组合物,例如副粘病毒SV5株的F蛋白。 该重组Rhabdovirus可以表达其他非Rhabdovirus附着蛋白和/或增强子蛋白。 本发明还涉及制备表达F蛋白的重组杆状病毒的方法。 这些重组组合物可用于研究目的,以及用于治疗疾病的诊断和治疗组合物。

    Bioelectrodynamics Modulation Method
    4.
    发明申请

    公开(公告)号:US20170232253A1

    公开(公告)日:2017-08-17

    申请号:US15044972

    申请日:2016-02-16

    IPC分类号: A61N1/20 A61N1/04 A61K33/14

    CPC分类号: A61N1/20 A61K33/14 A61N1/0472

    摘要: Disclosed are methods and devices utilizing bioelectrodynamics for the therapeutic treatment of disorders in a subject in need thereof with an electric field or electromagnetic field therapy. The methods and devices provide an inhibitory effect on growth of cancer cells that are exposed to an electromagnetic field generated by a CETS unit. Cancer cells may arrest proliferation and enter apoptosis by activation of the unfolded protein response (UPR), TNF/TRAIL, and p53 oncogene activation. The methods and devices may be used to enhance wound healing with exposure to an electromagnetic field generated by a CETS unit. Noncancerous cells may show a significant increase in cell migration with no activation of apoptosis pathways.